查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1967730

血液透析和腹膜透析市场－全球产业规模、份额、趋势、机会、预测：按类型、产品、最终用户、地区和竞争格局划分，2021-2031年

Hemodialysis and Peritoneal Dialysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Product, By End user, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球血液透析和腹膜透析市场预计将从 2025 年的 801.2 亿美元成长到 2031 年的 1,199.1 亿美元，复合年增长率为 6.95%。

血液透析使用外部装置过滤血液，而腹膜透析则利用腹腔内的腹膜作为天然的内部过滤器。该市场的成长主要受末期肾功能衰竭盛行率上升的驱动，而末期肾衰竭的盛行率上升与全球人口老化以及糖尿病、高血压等文明病的增加密切相关。这些因素使得维持生命对肾臟替代疗法的需求变得至关重要，因此，无论技术如何进步，需求都将保持强劲。根据国际肾臟病学会估计，到2023年，全球将有约8.5亿人患有慢性肾臟病，凸显了该领域面临的巨大健康负担。

市场概览
预测期 2027-2031
市场规模：2025年 801.2亿美元
市场规模：2031年 1199.1亿美元
复合年增长率：2026-2031年 6.95%
成长最快的细分市场 血液透析
最大的市场 北美洲

儘管需求强劲，但阻碍市场扩张的一大挑战是熟练的医疗专业人员严重短缺，包括肾臟科医生和透析护士，而这些专业人员是开展复杂治疗所必需的。这种短缺限制了透析中心的运作能力，并限制了患者获得治疗的机会，尤其是在基础设施本已捉襟见肘的发展中地区。此外，长期治疗的高昂费用以及各地不同的报销政策也构成了透析服务普及和发展的巨大经济障碍。

市场驱动因素

全球慢性肾臟病和末期肾功能衰竭盛行率的不断上升是推动市场扩张的主要动力。这主要是由于糖尿病和高血压文明病的发病率不断攀升，这些疾病会加速肾衰竭的进展，从而不可避免地对维持生命的治疗产生了持续的需求，尤其是在老龄化人口中。这种人口结构的变化要求透析网路具备强大的运作能力，以应对不断增长的患者数量。为了说明这项需求的规模，DaVita 在其 2023 年第四季财报中指出，截至 2023 年底，其网路已为约 250,200 名患者提供透析服务，这凸显了需要每日或每週接受维持生命治疗的庞大患者群体的存在。

同时，随着经济实惠的居家透析疗法日益普及，市场结构的重塑。医疗系统和保险公司正积极推广居家透析，以减轻传统机构治疗的经济负担。同时，越来越多的患者因其便利性和更高的生活品质而选择这种治疗方法。携带式设备的科技进步进一步加速了这一转变，使更多患者能够享受居家透析的益处。根据费森尤斯医疗照护2023年非财务集团报告，截至2023年12月31日，该公司在全球拥有31,258名居家透析患者。这项转变得到了大量投资的支持，百特国际2023年全年在美国的持续经营收入达70亿美元，反映出大量资金流入肾臟护理市场。

市场挑战

熟练医护人员的严重短缺是限制全球血液透析和腹膜透析市场扩张的主要瓶颈。儘管人口结构变化持续推高肾臟替代疗法的需求，但透析中心的运作能力往往并非受限于设备短缺，而是难以招募合格的医护人员。人员短缺直接阻碍了新设施的建立，降低了现有诊所的患者周转率，并有效地抑制了高需求地区的产生收入。因此，製造商和服务提供者的成长受到限制，因为他们的技术能否被广泛接受，很大程度上取决于能否获得训练有素的医护人员来执行治疗。

根据国际肾臟病学会的数据，到2024年，约64%的调查对象国家将面临肾臟科医师短缺，58%的国家将面临透析护理师短缺。新兴经济体的情况尤其严峻，因为这些国家患者数量与临床专业人才之间的差距最大。这场人力资源危机限制了基本医疗服务的提供，阻碍了市场充分利用慢性肾臟病病率不断上升的机会，减缓了整个产业的成长动能。

市场趋势

永续和环保透析技术的兴起正迅速成为该行业的重要趋势，旨在减轻传统肾臟治疗对环境的巨大影响。由于传统血液透析过程消耗大量资源，需要大量的水和电，製造商和服务供应商正致力于设计环保系统，以在不影响临床品质的前提下最大限度地减少废弃物。这项转变的特点是实施节水通讯协定并开发节能基础设施，以满足全球环境、社会和管治(ESG) 标准。根据 DaVita 发布的《2024 年社区护理报告》，该公司透过节能计划在 2024 年实现了超过 7,500 万加仑的节水量，这充分展现了这些永续性的切实成果。

同时，穿戴式和可携式透析设备的研发正在从根本上改变肾臟替代疗法的技术框架，使治疗摆脱了笨重、繁琐且固定的基础设施。与受报销模式驱动的居家医疗普遍趋势不同，这一趋势尤其关注那些能够使紧凑型一体化主机以移动形式提供医院级疗效的创新技术。这些进步不仅因其以患者为中心的设计而备受关注，更因其在空间和移动性至关重要的急诊和亚急性临床环境中的多功能性而备受瞩目。根据Outset Medical发布的“2024年第四季度及全年财务业绩报告”，该公司Tablo主机的安装量已达到约6000台，同比增长10%，表明市场对这一新一代平台的需求强劲。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球血液透析与腹膜透析市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依类型（血液透析、腹膜透析）
    • 依产品（设备、耗材、服务）分类
    • 依最终使用者（居家照护、医院）划分
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美血液透析与腹膜透析市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲血液透析与腹膜透析市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区血液透析和腹膜透析市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲血液透析和腹膜透析市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲血液透析与腹膜透析市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章 全球血液透析与腹膜透析市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Baxter International Inc
  • B. Braun Melsungen AG
  • Fresenius Medical Care AG
  • Medtronic, Inc
  • Asahi Kasei Medical Co., Ltd
  • Nipro Corp
  • DaVita Inc
  • Becton Dickinson & Co
  • Nikkiso Co., Ltd

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 23239

The Global Hemodialysis and Peritoneal Dialysis Market is projected to grow from USD 80.12 Billion in 2025 to USD 119.91 Billion by 2031, registering a CAGR of 6.95%. While hemodialysis functions by using an external machine to filter blood, peritoneal dialysis utilizes the peritoneum within the abdomen as an internal natural filter. The market is primarily propelled by the increasing prevalence of end-stage renal disease, which is closely linked to the aging global population and the rising incidence of lifestyle-dependent conditions such as diabetes and hypertension. These factors create a fundamental need for life-sustaining renal replacement therapies, ensuring demand remains robust regardless of technological shifts. According to the International Society of Nephrology, approximately 850 million individuals globally were estimated to be affected by chronic kidney disease in 2023, underscoring the massive health burden supporting this sector.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 80.12 Billion
Market Size 2031USD 119.91 Billion
CAGR 2026-20316.95%
Fastest Growing SegmentHemodialysis
Largest MarketNorth America

Despite this strong demand, a significant challenge impeding market expansion is the acute shortage of skilled healthcare professionals, including nephrologists and specialized dialysis nurses, required to administer these complex treatments. This workforce scarcity restricts the operational capacity of dialysis centers and limits patient access to care, particularly in developing regions where infrastructure is already strained. Furthermore, the high recurring costs associated with long-term therapy and inconsistent reimbursement policies across different jurisdictions create substantial economic barriers that hinder the broader accessibility and growth of dialysis services.

Market Driver

The escalating global prevalence of chronic kidney disease and end-stage renal disease serves as the primary catalyst for market expansion, fundamentally driven by the rising incidence of diabetes and hypertension. As these lifestyle-dependent conditions accelerate the progression of renal failure, they create an unavoidable and sustained demand for life-sustaining therapies, particularly among the aging geriatric population. This demographic shift necessitates robust operational capacities within dialysis networks to manage increasing patient volumes. Illustrating the scale of this need, DaVita Inc. reported in its '4th Quarter 2023 Results' that it provided dialysis services to approximately 250,200 patients across its network by the end of 2023, highlighting the vast population requiring daily or weekly life-support treatments.

Concurrently, the market is being reshaped by a growing adoption of cost-effective home-based dialysis modalities. Healthcare systems and insurance providers are increasingly incentivizing home dialysis to alleviate the financial burden of traditional in-center treatments, while patients favor the modality for its convenience and improved quality of life. Technological advancements in portable devices have further facilitated this transition, enabling broader patient uptake. According to Fresenius Medical Care's 'Non-financial Group Report 2023', the number of their patients receiving home dialysis worldwide reached 31,258 as of December 31, 2023. This shift is supported by substantial investment; Baxter International reported that sales from continuing operations in the U.S. alone totaled $7.00 billion for the full year 2023, reflecting significant capital flow into the renal care market.

Market Challenge

The acute shortage of skilled healthcare professionals represents a critical bottleneck restricting the expansion of the global hemodialysis and peritoneal dialysis market. While demand for renal replacement therapies continues to rise due to demographic shifts, the operational capacity of dialysis centers is frequently capped by the unavailability of qualified staff rather than a lack of equipment. This workforce deficit directly impedes the establishment of new facilities and reduces patient turnover in existing clinics, effectively stalling revenue generation in high-demand areas. Consequently, manufacturers and service providers face a ceiling on growth as the adoption of their technologies depends heavily on the availability of trained personnel to administer care.

According to the International Society of Nephrology, in 2024, approximately 64% of surveyed countries reported a shortage of nephrologists, while 58% reported a deficit in dialysis nurses. This scarcity is particularly detrimental in emerging economies where the gap between patient volume and available clinical expertise is widest. By limiting the delivery of essential treatments, this human resource crisis prevents the market from fully capitalizing on the escalating prevalence of chronic kidney disease, thereby dampening overall industry momentum.

Market Trends

The emergence of sustainable and green dialysis technologies is rapidly becoming a critical trend as the industry seeks to mitigate the high environmental footprint associated with traditional renal care. Conventional hemodialysis processes are resource-intensive, consuming vast quantities of water and electricity, which drives manufacturers and service providers to engineer eco-friendly systems capable of minimizing waste without compromising clinical quality. This shift is characterized by the implementation of water conservation protocols and energy-efficient infrastructure to align with global environmental, social, and governance (ESG) standards. According to DaVita Inc.'s '2024 Community Care' report, the company saved more than 75 million gallons of water through efficiency projects in 2024, illustrating the tangible impact of these sustainability initiatives.

Simultaneously, the development of wearable and portable dialysis devices is fundamentally altering the technological framework of renal replacement therapy by decoupling treatment from heavy, stationary infrastructure. Unlike the general shift toward home care driven by reimbursement models, this trend focuses specifically on engineering innovations that allow for compact, all-in-one consoles to offer hospital-grade efficacy in mobile formats. These advancements are gaining traction not only for their patient-centric design but also for their versatility in acute and sub-acute clinical settings where space and mobility are premium assets. According to Outset Medical, Inc.'s 'Fourth Quarter and Full Year 2024 Financial Results', the installed base for its Tablo console reached nearly 6,000 units, representing a 10 percent growth in 2024, signaling a robust market appetite for these next-generation platforms.

Key Market Players

  • Baxter International Inc
  • B. Braun Melsungen AG
  • Fresenius Medical Care AG
  • Medtronic, Inc
  • Asahi Kasei Medical Co., Ltd
  • Nipro Corp
  • DaVita Inc
  • Becton Dickinson & Co
  • Nikkiso Co., Ltd

Report Scope

In this report, the Global Hemodialysis and Peritoneal Dialysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hemodialysis and Peritoneal Dialysis Market, By Type

  • Hemodialysis
  • Peritoneal Dialysis

Hemodialysis and Peritoneal Dialysis Market, By Product

  • Devices
  • Consumables
  • Services

Hemodialysis and Peritoneal Dialysis Market, By End user

  • Home-based
  • Hospital-based

Hemodialysis and Peritoneal Dialysis Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hemodialysis and Peritoneal Dialysis Market.

Available Customizations:

Global Hemodialysis and Peritoneal Dialysis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hemodialysis and Peritoneal Dialysis Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Hemodialysis, Peritoneal Dialysis)
    • 5.2.2. By Product (Devices, Consumables, Services)
    • 5.2.3. By End user (Home-based, Hospital-based)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Hemodialysis and Peritoneal Dialysis Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Product
    • 6.2.3. By End user
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Hemodialysis and Peritoneal Dialysis Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By End user
    • 6.3.2. Canada Hemodialysis and Peritoneal Dialysis Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By End user
    • 6.3.3. Mexico Hemodialysis and Peritoneal Dialysis Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By End user

7. Europe Hemodialysis and Peritoneal Dialysis Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Product
    • 7.2.3. By End user
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Hemodialysis and Peritoneal Dialysis Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By End user
    • 7.3.2. France Hemodialysis and Peritoneal Dialysis Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By End user
    • 7.3.3. United Kingdom Hemodialysis and Peritoneal Dialysis Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By End user
    • 7.3.4. Italy Hemodialysis and Peritoneal Dialysis Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By End user
    • 7.3.5. Spain Hemodialysis and Peritoneal Dialysis Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By End user

8. Asia Pacific Hemodialysis and Peritoneal Dialysis Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Product
    • 8.2.3. By End user
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Hemodialysis and Peritoneal Dialysis Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By End user
    • 8.3.2. India Hemodialysis and Peritoneal Dialysis Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By End user
    • 8.3.3. Japan Hemodialysis and Peritoneal Dialysis Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By End user
    • 8.3.4. South Korea Hemodialysis and Peritoneal Dialysis Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By End user
    • 8.3.5. Australia Hemodialysis and Peritoneal Dialysis Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By End user

9. Middle East & Africa Hemodialysis and Peritoneal Dialysis Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Product
    • 9.2.3. By End user
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Hemodialysis and Peritoneal Dialysis Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By End user
    • 9.3.2. UAE Hemodialysis and Peritoneal Dialysis Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By End user
    • 9.3.3. South Africa Hemodialysis and Peritoneal Dialysis Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By End user

10. South America Hemodialysis and Peritoneal Dialysis Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Product
    • 10.2.3. By End user
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Hemodialysis and Peritoneal Dialysis Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By End user
    • 10.3.2. Colombia Hemodialysis and Peritoneal Dialysis Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By End user
    • 10.3.3. Argentina Hemodialysis and Peritoneal Dialysis Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Hemodialysis and Peritoneal Dialysis Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Baxter International Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. B. Braun Melsungen AG
  • 15.3. Fresenius Medical Care AG
  • 15.4. Medtronic, Inc
  • 15.5. Asahi Kasei Medical Co., Ltd
  • 15.6. Nipro Corp
  • 15.7. DaVita Inc
  • 15.8. Becton Dickinson & Co
  • 15.9. Nikkiso Co., Ltd

16. Strategic Recommendations

17. About Us & Disclaimer